Wednesday - May 7, 2025
BLOOMFIELD, Conn., Dec. 15, 2023 /PRNewswire/ -- To help school-age children and their families better access community resources and support, The Cigna Group Foundation today announced it has committed nearly $3.3 million to reduce food insecurity and support youth mental health. These new grants are part of The Cigna Group Foundation's Healthier Kids For Our Future® initiative, which has awarded $25 million to nearly 150 nonprofits in the United States since 2019.
"It's critical that we help students across the country thrive – academically, physically, and emotionally," said Melissa Skottegaard, chairperson of The Cigna Group Foundation. "The extraordinary organizations are embedded within their local communities, which allows them to know firsthand how to best solve some of these tough challenges. We are energized by the innovation these groups have shown and the continued positive impact they will make."
Some of the organizations that The Cigna Group Foundation partnered with this year are:
About The Cigna Group Foundation
The Cigna Group Foundation is a private foundation funded by contributions from The Cigna Group (NYSE:CI) and its subsidiaries. The Cigna Group Foundation supports organizations sharing its commitment to enhancing the health of individuals and families, and the well-being of their communities, with a special focus on those communities where employees of The Cigna Group live and work.
Media Contact
Kelly Mathews
(423) 260-9267
Kelly.Mathews@Evernorth.com
Last Trade: | US$334.35 |
Daily Change: | 1.34 0.40 |
Daily Volume: | 1,197,936 |
Market Cap: | US$93.000B |
January 30, 2025 October 31, 2024 September 12, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load